JP2014221827A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014221827A5 JP2014221827A5 JP2014155149A JP2014155149A JP2014221827A5 JP 2014221827 A5 JP2014221827 A5 JP 2014221827A5 JP 2014155149 A JP2014155149 A JP 2014155149A JP 2014155149 A JP2014155149 A JP 2014155149A JP 2014221827 A5 JP2014221827 A5 JP 2014221827A5
- Authority
- JP
- Japan
- Prior art keywords
- gastrointestinal tract
- effervescent
- upper gastrointestinal
- effervescent tablet
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007938 effervescent tablet Substances 0.000 claims 13
- 210000002438 upper gastrointestinal tract Anatomy 0.000 claims 8
- 230000002757 inflammatory effect Effects 0.000 claims 7
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 claims 4
- 229960004436 budesonide Drugs 0.000 claims 4
- 210000000214 mouth Anatomy 0.000 claims 3
- 239000002324 mouth wash Substances 0.000 claims 3
- 229940051866 mouthwash Drugs 0.000 claims 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 2
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- 206010064212 Eosinophilic oesophagitis Diseases 0.000 claims 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 206010028116 Mucosal inflammation Diseases 0.000 claims 1
- 201000010927 Mucositis Diseases 0.000 claims 1
- 238000002512 chemotherapy Methods 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 claims 1
- 229960000878 docusate sodium Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 201000000708 eosinophilic esophagitis Diseases 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 230000002458 infectious effect Effects 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 claims 1
- 239000011973 solid acid Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08013091.7 | 2008-07-21 | ||
| EP08013091A EP2151235B1 (de) | 2008-07-21 | 2008-07-21 | Pharmazeutische Formulierung zur Behandlung des oberen Verdauungstraktes |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011519101A Division JP5616889B2 (ja) | 2008-07-21 | 2009-07-02 | 上部消化管治療用医薬製剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014221827A JP2014221827A (ja) | 2014-11-27 |
| JP2014221827A5 true JP2014221827A5 (enExample) | 2015-02-19 |
| JP6209495B2 JP6209495B2 (ja) | 2017-10-04 |
Family
ID=39951664
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011519101A Expired - Fee Related JP5616889B2 (ja) | 2008-07-21 | 2009-07-02 | 上部消化管治療用医薬製剤 |
| JP2014155149A Expired - Fee Related JP6209495B2 (ja) | 2008-07-21 | 2014-07-30 | 上部消化管治療用医薬製剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011519101A Expired - Fee Related JP5616889B2 (ja) | 2008-07-21 | 2009-07-02 | 上部消化管治療用医薬製剤 |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US8580300B2 (enExample) |
| EP (2) | EP2151235B1 (enExample) |
| JP (2) | JP5616889B2 (enExample) |
| CN (1) | CN102159196B (enExample) |
| AT (1) | ATE498396T1 (enExample) |
| AU (1) | AU2009273361B2 (enExample) |
| CA (1) | CA2731312C (enExample) |
| CY (2) | CY1111878T1 (enExample) |
| DE (1) | DE502008002621D1 (enExample) |
| DK (2) | DK2151235T3 (enExample) |
| EA (1) | EA018465B1 (enExample) |
| ES (2) | ES2358158T3 (enExample) |
| HR (2) | HRP20130171T1 (enExample) |
| IL (1) | IL210779A (enExample) |
| ME (2) | ME01256B (enExample) |
| NZ (1) | NZ590593A (enExample) |
| PL (2) | PL2151235T3 (enExample) |
| PT (2) | PT2151235E (enExample) |
| RS (2) | RS51649B (enExample) |
| SI (2) | SI2151235T1 (enExample) |
| UA (1) | UA100759C2 (enExample) |
| WO (1) | WO2010009961A1 (enExample) |
| ZA (1) | ZA201100283B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8895064B2 (en) | 1999-06-14 | 2014-11-25 | Cosmo Technologies Limited | Controlled release and taste masking oral pharmaceutical composition |
| WO2000076478A1 (en) | 1999-06-14 | 2000-12-21 | Cosmo S.P.A. | Controlled release and taste masking oral pharmaceutical compositions |
| US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| PT2151235E (pt) * | 2008-07-21 | 2011-03-21 | Falk Pharma Gmbh | Formulação farmacêutica para o tratamento do trato digestivo superior |
| CA2765033C (en) | 2009-06-12 | 2020-07-14 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
| CN106421797A (zh) | 2009-10-01 | 2017-02-22 | 艾戴尔医药公司 | 口服给予的皮质类固醇组合物 |
| US10154964B2 (en) | 2011-09-07 | 2018-12-18 | Cosmo Technologies Limited | Controlled release and taste masking oral pharmaceutical composition |
| WO2015034678A2 (en) | 2013-09-06 | 2015-03-12 | Aptalis Pharmatech, Inc. | Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis |
| PL2886108T5 (pl) | 2013-12-23 | 2023-02-27 | Dr. Falk Pharma Gmbh | Zoptymalizowana formulacja farmaceutyczna do leczenia zmian zapalnych przełyku |
| TWI777515B (zh) | 2016-08-18 | 2022-09-11 | 美商愛戴爾製藥股份有限公司 | 治療嗜伊紅性食道炎之方法 |
| WO2020084530A1 (en) | 2018-10-24 | 2020-04-30 | Ferring B.V. | Mucoadhesive pharmaceutical compositions of corticosteroids |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4332394A1 (de) | 1993-09-23 | 1995-03-30 | Falk Pharma Gmbh | Budesonid-Pellets mit kontrolliertem Freigabeprofil und Verfahren zu ihrer Herstellung |
| US5639475A (en) * | 1995-02-03 | 1997-06-17 | Eurand America, Incorporated | Effervescent microcapsules |
| US5607697A (en) * | 1995-06-07 | 1997-03-04 | Cima Labs, Incorporated | Taste masking microparticles for oral dosage forms |
| US5807578A (en) * | 1995-11-22 | 1998-09-15 | Lab Pharmaceutical Research International Inc. | Fast-melt tablet and method of making same |
| US5807577A (en) * | 1995-11-22 | 1998-09-15 | Lab Pharmaceutical Research International Inc. | Fast-melt tablet and method of making same |
| GB9611364D0 (en) * | 1996-05-31 | 1996-08-07 | Smithkline Beecham Plc | Composition |
| US6350470B1 (en) * | 1998-04-29 | 2002-02-26 | Cima Labs Inc. | Effervescent drug delivery system for oral administration |
| JP3818789B2 (ja) * | 1999-02-18 | 2006-09-06 | 三菱化学フーズ株式会社 | 易崩壊性錠剤 |
| WO2003006629A1 (en) | 2001-07-11 | 2003-01-23 | Toshirou Sekine | Culturing method and device for photosynthetic microbes |
| CA2461042A1 (en) * | 2001-09-25 | 2003-04-03 | Ashish Madan | Process for the preparation of fast dissolving dosage form |
| WO2003043518A2 (en) * | 2001-11-20 | 2003-05-30 | Dmi Biosciences, Inc. | Methods and products for oral care |
| JP2005526095A (ja) * | 2002-03-20 | 2005-09-02 | エラン ファーマ インターナショナル，リミティド | 脆砕性の低い急速溶解投与剤型 |
| SE0401031D0 (sv) * | 2004-04-22 | 2004-04-22 | Duocort Ab | A new glucocorticoid replacement therapy |
| US20060013873A1 (en) * | 2004-07-16 | 2006-01-19 | Chih-Chiang Yang | Bioadhesive dosage form of steroids |
| US20070071817A1 (en) * | 2005-09-26 | 2007-03-29 | Phyzz, Inc. | Effervescent oral care compositions and method of use |
| US20070191323A1 (en) * | 2006-02-15 | 2007-08-16 | Verus Pharmaceuticals, Inc. | Stable corticosteroid mixtures |
| SI2170348T1 (sl) * | 2007-06-22 | 2016-12-30 | Dompe Farmaceutici S.P.A. | Šumeče tablete za inhalacijsko uporabo |
| WO2009043844A2 (en) * | 2007-10-01 | 2009-04-09 | Laboratorios Lesvi, S.L. | Orodispersible tablets |
| PT2151235E (pt) * | 2008-07-21 | 2011-03-21 | Falk Pharma Gmbh | Formulação farmacêutica para o tratamento do trato digestivo superior |
| CA2765033C (en) * | 2009-06-12 | 2020-07-14 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
-
2008
- 2008-07-21 PT PT08013091T patent/PT2151235E/pt unknown
- 2008-07-21 PL PL08013091T patent/PL2151235T3/pl unknown
- 2008-07-21 DK DK08013091.7T patent/DK2151235T3/da active
- 2008-07-21 ME MEP-2011-46A patent/ME01256B/me unknown
- 2008-07-21 SI SI200830187T patent/SI2151235T1/sl unknown
- 2008-07-21 DE DE502008002621T patent/DE502008002621D1/de active Active
- 2008-07-21 EP EP08013091A patent/EP2151235B1/de active Active
- 2008-07-21 AT AT08013091T patent/ATE498396T1/de active
- 2008-07-21 ES ES08013091T patent/ES2358158T3/es active Active
- 2008-07-21 RS RS20110100A patent/RS51649B/sr unknown
-
2009
- 2009-02-07 UA UAA201101686A patent/UA100759C2/uk unknown
- 2009-07-02 US US13/054,844 patent/US8580300B2/en not_active Expired - Fee Related
- 2009-07-02 NZ NZ590593A patent/NZ590593A/en unknown
- 2009-07-02 SI SI200930502T patent/SI2306988T1/sl unknown
- 2009-07-02 CN CN2009801358800A patent/CN102159196B/zh not_active Expired - Fee Related
- 2009-07-02 ES ES09800023T patent/ES2399321T3/es active Active
- 2009-07-02 EP EP09800023A patent/EP2306988B1/de not_active Revoked
- 2009-07-02 PT PT98000235T patent/PT2306988E/pt unknown
- 2009-07-02 ME MEP-2013-22A patent/ME01494B/me unknown
- 2009-07-02 RS RS20130071A patent/RS52662B/sr unknown
- 2009-07-02 CA CA2731312A patent/CA2731312C/en not_active Expired - Fee Related
- 2009-07-02 WO PCT/EP2009/058320 patent/WO2010009961A1/de not_active Ceased
- 2009-07-02 EA EA201100229A patent/EA018465B1/ru not_active IP Right Cessation
- 2009-07-02 DK DK09800023.5T patent/DK2306988T3/da active
- 2009-07-02 JP JP2011519101A patent/JP5616889B2/ja not_active Expired - Fee Related
- 2009-07-02 AU AU2009273361A patent/AU2009273361B2/en not_active Ceased
- 2009-07-02 HR HRP20130171AT patent/HRP20130171T1/hr unknown
- 2009-07-02 PL PL09800023T patent/PL2306988T3/pl unknown
-
2011
- 2011-01-11 ZA ZA2011/00283A patent/ZA201100283B/en unknown
- 2011-01-20 IL IL210779A patent/IL210779A/en active IP Right Grant
- 2011-03-11 CY CY20111100274T patent/CY1111878T1/el unknown
- 2011-03-23 HR HR20110208T patent/HRP20110208T1/hr unknown
-
2013
- 2013-02-26 CY CY20131100174T patent/CY1113719T1/el unknown
- 2013-10-23 US US14/061,578 patent/US20140079646A1/en not_active Abandoned
-
2014
- 2014-07-30 JP JP2014155149A patent/JP6209495B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014221827A5 (enExample) | ||
| JP2012255026A5 (enExample) | ||
| PL3793534T3 (pl) | Tabletka doustna do dostarczania składników czynnych do przewodu żołądkowo-jelitowego | |
| SG10201810985XA (en) | Tofacitinib oral sustained release dosage forms | |
| WO2011111027A3 (en) | Oral dispersible delayed release tablet formulation | |
| JP2014198723A5 (enExample) | ||
| JP2016540021A5 (enExample) | ||
| MX2012003204A (es) | Forma de dosificacion solida oral que contiene nanoparticulas y proceso para su formulacion utilizando gelatina de pescado. | |
| CO2017012670A2 (es) | Unidad de dosificación orodispersable que contiene un componente estetrol | |
| JP2015038135A5 (enExample) | ||
| ECSP15042897A (es) | Formulaciones orales de deferasirox | |
| AR091351A1 (es) | Formulaciones de bromocriptina, metodo para mejorar el control glucemico y metodo para la fabricacion | |
| CL2013000677A1 (es) | Composicion farmaceutica en forma de tabletas que comprenden microgranulos gastrointestinales que contienen 100 a 800 mg de rifaximina, hasta 30% p/p de excipientes extragranulares y un recubrimiento formador de pelicula; y uso para tratar una enfermedad infecciosa y/o inflamatoria del intestino, tal como la enfermedad de crohn. | |
| HRP20110208T1 (hr) | Farmaceutska formulacija za liječenje gornjeg probavnog sustava | |
| JP2015510916A5 (enExample) | ||
| PL3003285T3 (pl) | Stała farmaceutyczna postać dawkowania do uwalniania co najmniej dwóch substancji czynnych w jamie ustnej | |
| PH12015500823A1 (en) | Modified release formulations for oprozomib | |
| JP2013523676A5 (enExample) | ||
| BR112014014795A2 (pt) | sistema de pélete de multiunidade de liberação imediata | |
| JP2014210824A5 (enExample) | ||
| JP2016503803A5 (enExample) | ||
| EP2384745A3 (en) | Modified release pharmaceutical compositions of dexlansoprazole | |
| EA201691034A1 (ru) | Композиции в твердой форме с замедленным высвобождением для перорального введения | |
| JP2015120758A5 (enExample) | ||
| WO2011093815A3 (en) | Pharmaceutical compositions comprising formoterol and mometasone |